RedHill Biopharma Ltd
TEL AVIV, Israel · Biotechnology, Healthcare, Health Care
RedHill Biopharma Ltd. (Nasdaq: RDHL) is a specialty biopharmaceutical company focused on developing and commercializing therapies for gastrointestinal, infectious, and oncological diseases in the U.S. The company markets Talicia®, an FDA-approved treatment for H. pylori infection, and is advancing late-stage programs including opaganib, a first-in-class SPHK2 inhibitor; RHB-204 for Crohn’s diseas
You have opened 5 full company profiles today. Create an account to keep reading them. Create an account
Key facts
- Headquarters
- TEL AVIV, Israel
- Employees
- Unknown
- Industries
- Biotechnology, Healthcare, Health Care
- Status
- Public (RDHL)
- Website
- http://www.redhillbio.com/
- Company page
Recent activity at RedHill Biopharma Ltd
- : RedHill acquires Ferring's Rebyota and Clenpiq rights
- : RedHill Biopharma secures $6 million via a private placement, aiming for up to $19.4 million. The offering is led by H.C. Wainwright & Co.
- : RedHill Biopharma secures $4 million strategic investment from Cumberland Pharmaceuticals for Talicia co-commercialization, enhancing sales growth.
Employee benefit plans
RedHill Biopharma Ltd files 4 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Oct 2026.
About RedHill Biopharma Ltd: questions and answers
What does RedHill Biopharma Ltd do?
RedHill Biopharma Ltd. (Nasdaq: RDHL) is a specialty biopharmaceutical company focused on developing and commercializing therapies for gastrointestinal, infectious, and oncological diseases in the U.S. The company markets Talicia®, an FDA-approved treatment for H. pylori infection, and is advancing late-stage programs including opaganib, a first-in-class SPHK2 inhibitor; RHB-204 for Crohn’s diseas
Where is RedHill Biopharma Ltd headquartered?
RedHill Biopharma Ltd is headquartered in TEL AVIV, Israel.
What is the latest news on RedHill Biopharma Ltd?
On Sep 01, 2026, RedHill acquires Ferring's Rebyota and Clenpiq rights
Is RedHill Biopharma Ltd a public company?
Yes. RedHill Biopharma Ltd is publicly traded under the ticker RDHL.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy